MetaCap

Enanta Pharmaceuticals (ENTA) News

NASDAQ: ENTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.62-0.36 (-4.51%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ENTA news summary

We found 5 recent headlines mentioning Enanta Pharmaceuticals (ENTA): 3 in the past week and 5 in the past 30 days, most often from Nasdaq, Business Wire. For price context, ENTA is down 4.51% at $7.62. The most recent story, "Enanta Pharmaceuticals Becomes Oversold (ENTA)", was published by Nasdaq on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Enanta Pharmaceuticals headlines

Compare ENTA